最新报道:Litecoin (LTC) surged 40% to $124 after MEI Pharma purchased $110M worth of LTC (929,548 coins) for its treasury, marking the first U.S. public company adoption. Creator Charlie Lee hailed the move as an "institutional step forward," enhancing LTC's credibility as a reserve asset. Analysts project a short-term target of $150 based on historical patterns, though the RSI at 71 indicates overbought conditions and potential correction. Despite near-term selling pressure from exchange inflows, LTC's role as a low-cost Bitcoin alternative and institutional support bolster long-term optimism.